| GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 4.69% (3/64) | 6.08 | 1.2e-05 | 0.009495 |
| GO:0050686 | negative regulation of mRNA processing | 4.69% (3/64) | 5.84 | 2e-05 | 0.010671 |
| GO:0050684 | regulation of mRNA processing | 7.81% (5/64) | 3.71 | 4.2e-05 | 0.013438 |
| GO:0003960 | NADPH:quinone reductase activity | 3.12% (2/64) | 7.25 | 7.3e-05 | 0.014639 |
| GO:0042180 | cellular ketone metabolic process | 7.81% (5/64) | 4.15 | 1e-05 | 0.015341 |
| GO:0006376 | mRNA splice site selection | 4.69% (3/64) | 5.25 | 6.9e-05 | 0.015652 |
| GO:0033119 | negative regulation of RNA splicing | 4.69% (3/64) | 5.52 | 4e-05 | 0.015793 |
| GO:1990446 | U1 snRNP binding | 3.12% (2/64) | 6.35 | 0.000273 | 0.016767 |
| GO:0019884 | antigen processing and presentation of exogenous antigen | 3.12% (2/64) | 6.35 | 0.000273 | 0.016767 |
| GO:0044249 | cellular biosynthetic process | 32.81% (21/64) | 1.23 | 0.000107 | 0.017016 |
| GO:0110165 | cellular anatomical entity | 81.25% (52/64) | 0.43 | 0.000259 | 0.017242 |
| GO:0003674 | molecular_function | 82.81% (53/64) | 0.47 | 6.5e-05 | 0.017295 |
| GO:1901661 | quinone metabolic process | 4.69% (3/64) | 5.08 | 9.8e-05 | 0.017336 |
| GO:0071826 | ribonucleoprotein complex subunit organization | 7.81% (5/64) | 3.1 | 0.000295 | 0.01744 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 6.25% (4/64) | 3.72 | 0.000252 | 0.0175 |
| GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 4.69% (3/64) | 4.52 | 0.000314 | 0.017906 |
| GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 3.12% (2/64) | 6.45 | 0.000237 | 0.01801 |
| GO:1901576 | organic substance biosynthetic process | 32.81% (21/64) | 1.14 | 0.000249 | 0.018032 |
| GO:0071704 | organic substance metabolic process | 59.38% (38/64) | 0.68 | 0.000228 | 0.018221 |
| GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.12% (2/64) | 6.55 | 0.000203 | 0.01909 |
| GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.12% (2/64) | 6.55 | 0.000203 | 0.01909 |
| GO:0050661 | NADP binding | 6.25% (4/64) | 3.75 | 0.000227 | 0.019096 |
| GO:0044281 | small molecule metabolic process | 25.0% (16/64) | 1.35 | 0.000349 | 0.019199 |
| GO:0022618 | ribonucleoprotein complex assembly | 7.81% (5/64) | 3.19 | 0.000226 | 0.020038 |
| GO:0006081 | cellular aldehyde metabolic process | 6.25% (4/64) | 3.54 | 0.0004 | 0.020565 |
| GO:0005575 | cellular_component | 82.81% (53/64) | 0.44 | 0.000143 | 0.020784 |
| GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.12% (2/64) | 6.01 | 0.000443 | 0.020793 |
| GO:0048002 | antigen processing and presentation of peptide antigen | 3.12% (2/64) | 6.01 | 0.000443 | 0.020793 |
| GO:0009987 | cellular process | 73.44% (47/64) | 0.49 | 0.000419 | 0.02086 |
| GO:0070990 | snRNP binding | 3.12% (2/64) | 6.08 | 0.000397 | 0.021107 |
| GO:0044237 | cellular metabolic process | 56.25% (36/64) | 0.73 | 0.0002 | 0.021215 |
| GO:0008150 | biological_process | 82.81% (53/64) | 0.43 | 0.000194 | 0.022122 |
| GO:0008152 | metabolic process | 62.5% (40/64) | 0.65 | 0.000192 | 0.02358 |
| GO:0009058 | biosynthetic process | 34.38% (22/64) | 1.13 | 0.000183 | 0.024276 |
| GO:1903311 | regulation of mRNA metabolic process | 7.81% (5/64) | 2.9 | 0.000562 | 0.025621 |
| GO:0022607 | cellular component assembly | 18.75% (12/64) | 1.56 | 0.000615 | 0.027256 |
| GO:0033987 | 2-hydroxyisoflavanone dehydratase activity | 3.12% (2/64) | 5.73 | 0.000653 | 0.02815 |
| GO:1903312 | negative regulation of mRNA metabolic process | 4.69% (3/64) | 4.13 | 0.000697 | 0.02924 |
| GO:0043484 | regulation of RNA splicing | 6.25% (4/64) | 3.31 | 0.000723 | 0.029584 |
| GO:0005685 | U1 snRNP | 3.12% (2/64) | 5.61 | 0.000773 | 0.030811 |
| GO:0032787 | monocarboxylic acid metabolic process | 14.06% (9/64) | 1.83 | 0.000918 | 0.034057 |
| GO:0009438 | methylglyoxal metabolic process | 3.12% (2/64) | 5.5 | 0.000902 | 0.03426 |
| GO:0042181 | ketone biosynthetic process | 4.69% (3/64) | 4.01 | 0.000884 | 0.0344 |
| GO:0005829 | cytosol | 29.69% (19/64) | 1.06 | 0.001125 | 0.039891 |
| GO:0003730 | mRNA 3'-UTR binding | 4.69% (3/64) | 3.9 | 0.001101 | 0.039921 |
| GO:0006743 | ubiquinone metabolic process | 3.12% (2/64) | 5.25 | 0.001268 | 0.041279 |
| GO:0006744 | ubiquinone biosynthetic process | 3.12% (2/64) | 5.25 | 0.001268 | 0.041279 |
| GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 3.12% (2/64) | 5.25 | 0.001268 | 0.041279 |
| GO:0043229 | intracellular organelle | 59.38% (38/64) | 0.57 | 0.001296 | 0.041349 |
| GO:0098588 | bounding membrane of organelle | 20.31% (13/64) | 1.38 | 0.001204 | 0.041736 |
| GO:0043333 | 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0043334 | 2-hexaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0043429 | 2-nonaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0018293 | protein-FAD linkage | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0034552 | respiratory chain complex II assembly | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0034553 | mitochondrial respiratory chain complex II assembly | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0001711 | endodermal cell fate commitment | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.56% (1/64) | 9.25 | 0.001637 | 0.043526 |
| GO:0000387 | spliceosomal snRNP assembly | 3.12% (2/64) | 5.04 | 0.001694 | 0.044289 |
| GO:0016052 | carbohydrate catabolic process | 7.81% (5/64) | 2.59 | 0.001476 | 0.045263 |
| GO:0043226 | organelle | 59.38% (38/64) | 0.56 | 0.001467 | 0.045892 |
| GO:0006090 | pyruvate metabolic process | 4.69% (3/64) | 3.63 | 0.001871 | 0.048142 |